Drugs Controller General Of India

Rediff.com » News » Drugs Controller General Of India

News for Drugs Controller General Of India

News
Business

AIIMS chief among volunteers for Covaxin's phase-3 trial

The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS in New Delhi on Thursday, with Dr M V Padma Srivastava, the chief of......

Covid vaccine to be available for every Indian till 2024: Poonawalla

Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford COVID-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and......

COVID-19 vaccine Covaxin enters phase-3 trials

Covid-19 vaccine, Covaxin, being developed by Bharat Biotech is now undergoing phase-3 trials, Krishna Ella, Chairman and Managing Director, Bharat Biotech said on Monday. Speaking virtually at a......

Bharat Biotech's Covid vaccine gets nod for Phase 3 trial

The Drugs Controller General of India on Friday permitted Bharat Biotech to conduct phase 3 clinical trials of its indigenously developed COVID-19 vaccine with certain conditions, officials said.......

Govt may remove plasma therapy as COVID-19 treatment

The Centre is considering to remove convalescent plasma therapy from the national clinical management protocol for COVID-19, a top Indian Council of Medical Research official said on Tuesday.......

Advertisers feel the heat of Bollywood drug abuse probe

Advertising agencies admitted that conversations had begun with their clients to exercise restraint while using brand endorsements featuring film actors whose names appeared in the probe. IMAGE:......

How complex is the process of getting approval for a vaccine?

Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. Ruchika Chitravanshi takes you through......

Dr Reddy's launches COVID-19 drug Avigan

Avigan comes in a complete therapy pack of 122 tablets with a two-year shelf life. Dr Reddy's Laboratories on Wednesday announced the launch of Avigan (favipiravir) 200 mg tablets in India. The......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......

At Rs 35 a pill, Sun Pharma's FluGuard is the cheapest favipiravir drug

Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease. Joining the long list of firms to launch its own......

Web results for Drugs Controller General Of India

Kiran Mazumdar-Shaw seeks quick regulatory processing after UK nod

She cited reports according to which the UK's medicines and healthcare products regulatory agency (MHRA) is likely to grant EUA by mid December. A... ...

https://economictimes.indiatimes.com/industry/healthcare/biotech/oxford-vaccine-kiran-mazumdar-shaw-seeks-quick-regulatory-processing-after-uk-nod/articleshow/79407927.cms

Bharat Biotech begins Phase-III trials for COVID-19 vaccine, Covaxin, with 26,000 volunteers

"This is India's first phase-III efficacy study for a Covid-19 vaccine, and the largest phase-III efficacy trial ever conducted in India," said... ...

https://economictimes.indiatimes.com/industry/healthcare/biotech/bharat-biotech-begins-phase-iii-trials-for-covid-19-vaccine-covaxin-with-26000-volunteers/articleshow/79254612.cms

First Batch of Russian Covid-19 Vaccine Sputnik V to Arrive in Kanpur Medical College for Phase 2, 3 Trials

The decision to conduct the human clinical trials of the vaccine was taken after Dr Reddy's Laboratories got approval from the Drugs Controller... ...

https://www.news18.com/news/india/first-batch-of-russian-covid-19-vaccine-sputnik-v-to-arrive-in-kanpur-medical-college-for-phase-2-3-trials-3082259.html

Zydus Cadila completes phase 2 clinical trial in Covid-19 patients with Hepatitis...

Zydus Cadila said it had conducted this study on the approval from the Drugs Controller General of India (DCGI) to investigate the role of... ...

https://www.hindustantimes.com/india-news/zydus-cadila-completes-phase-2-clinical-trial-in-covid-19-patients-with-hepatitis-c-biological-therapy-pegihep/story-SAZNpxaf3QdVkTzCWcxcTN.html

Feluda, the cheaper CRISPR based Covid test launched by Tata group

TataMD CHECK has been approved by Indian Council of Medical Research and Drug Controller General of India (DCGI) and will be available through... ...

https://www.hindustantimes.com/health/feluda-the-cheaper-crispr-based-covid-test-launched-by-tata-group/story-NURoWRmh7KE2OVKbTeFQsO.html

See All

Rediff News

Drugs Controller General Of India

News for Drugs Controller General Of India

AIIMS chief among volunteers for Covaxin's phase-3 trial

Covid vaccine to be available for every Indian till 2024: Poonawalla

COVID-19 vaccine Covaxin enters phase-3 trials

Bharat Biotech's Covid vaccine gets nod for Phase 3 trial

Govt may remove plasma therapy as COVID-19 treatment

Advertisers feel the heat of Bollywood drug abuse probe

How complex is the process of getting approval for a vaccine?

Dr Reddy's launches COVID-19 drug Avigan

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

At Rs 35 a pill, Sun Pharma's FluGuard is the cheapest favipiravir drug

Related Tags

Top Coverage News

US Presidential Elections 2016

Coming to India and making

India, through the eye of a camera

Commonwealth Games - 2014

The defence coverage of Rediff.com